FDA Approved: HEPARIN SODIUM — Original Application (Hospira, Inc.)

View source ↗

Summary

FDA approved an original ANDA for heparin sodium, enabling its generic commercialization by Hospira, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Pulmonary Embolism
• Thrombosis
• Venous Thromboembolism

Drugs mentioned

• HEPARIN SODIUM (HEPARIN SODIUM)

Snippet

ORIG AP for HEPARIN SODIUM (HEPARIN SODIUM)